A detailed history of Exane Derivatives transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Exane Derivatives holds 1,473 shares of BMRN stock, worth $98,101. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,473
Previous 1,889 22.02%
Holding current value
$98,101
Previous $145,000 15.86%
% of portfolio
0.08%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$71.48 - $86.85 $29,735 - $36,129
-416 Reduced 22.02%
1,473 $122,000
Q1 2022

Apr 22, 2022

SELL
$74.28 - $92.69 $16,341 - $20,391
-220 Reduced 10.43%
1,889 $145,000
Q4 2021

Jan 28, 2022

SELL
$71.72 - $91.47 $47,837 - $61,010
-667 Reduced 24.03%
2,109 $186,000
Q3 2021

Oct 26, 2021

SELL
$74.77 - $85.47 $21,907 - $25,042
-293 Reduced 9.55%
2,776 $214,000
Q2 2021

Jul 28, 2021

BUY
$75.51 - $84.79 $17,593 - $19,756
233 Added 8.22%
3,069 $256,000
Q1 2021

Apr 30, 2021

BUY
$74.73 - $90.69 $73,085 - $88,694
978 Added 52.64%
2,836 $214,000
Q4 2020

Jan 27, 2021

BUY
$72.61 - $90.2 $82,049 - $101,926
1,130 Added 155.22%
1,858 $162,000
Q1 2020

Apr 17, 2020

SELL
$71.37 - $96.85 $11,776 - $15,980
-165 Reduced 18.48%
728 $61,000
Q3 2019

Oct 15, 2019

SELL
$67.4 - $85.11 $337 - $425
-5 Reduced 0.56%
893 $60,000
Q2 2019

Jul 12, 2019

BUY
$80.35 - $93.9 $80 - $93
1 Added 0.11%
898 $0
Q1 2019

Apr 24, 2019

BUY
$84.2 - $98.62 $36,206 - $42,406
430 Added 92.08%
897 $0
Q4 2018

Jan 31, 2019

BUY
$80.14 - $106.07 $36,383 - $48,155
454 Added 3492.31%
467 $39,000
Q3 2018

Oct 24, 2018

SELL
$93.92 - $105.72 $123,504 - $139,021
-1,315 Reduced 99.02%
13 $0
Q2 2018

Jul 19, 2018

SELL
$76.01 - $99.03 $2,660 - $3,466
-35 Reduced 2.57%
1,328 $0
Q1 2018

Apr 30, 2018

BUY
$77.67 - $92.63 $103,378 - $123,290
1,331 Added 4159.38%
1,363 $0
Q4 2017

Jan 29, 2018

SELL
$80.76 - $95.13 $11,306 - $13,318
-140 Reduced 81.4%
32 $0
Q3 2017

Oct 18, 2017

BUY
$80.6 - $94.95 $13,863 - $16,331
172
172 $0

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.